A study of promoter and intronic markers of ApoI/Fas gene and the interaction with Fas ligand in relapsing multiple sclerosis

European Neurology

Volumn 52, Issue 1, 2004, Pages 12-17

  Lucas, Miguel ^a   Zayas, María D ^a   De Costa, Alzenira F ^a   Solano, Francisca ^a   Chadli, Amal ^a   Dinca, Luminita ^a   Izquierdo, Guillermo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Apoptosis; DRB1*1501; Fas; Fas ligand; Multiple sclerosis; Single nucleotide polymorphism

Indexed keywords

FAS ANTIGEN;

ADULT; ALLELE; ARTICLE; CHROMOSOME; CONTROLLED STUDY; DISEASE ASSOCIATION; EQUILIBRIUM CONSTANT; FEMALE; GENE FREQUENCY; GENE LOCATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALANINE; ANTIGENS, CD95; APOLIPOPROTEINS; DISABILITY EVALUATION; FAS LIGAND PROTEIN; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, HDL; MALE; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 4043089355     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079253     Document Type: Article

References (17)

1. Nagata S, Golstein P: The Fas death factor. Science 1995;267:1449-1456.
2. Famularo G, Nucera E, Marcellini S, De Simone C: Fas/Fas ligand on the road: An apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation. Med Hypotheses 1999;53:50-62.
3. Pender MP, Rist MJ: Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia. Glia 2001;36:137-144.
4. 1b augments activationinduced T cell death in multiple sclerosis patients. Lancet 1999;353:1413-1414.
5. Zayas MD, Lucas M, Solano F, Fernández-Pérez MJ, Izquierdo G: Association of CA repeat polymorphism upstream of the Fas ligand gene with multiple sclerosis. J Neuroimmunol 2001;116:238-241.
6. Huang QI, Morris D, Manolios N: Identification and characterisation of polymorphisms in the promoter of the human Apo-1/Fas (CD45) gene. Mol Immunol 1997;34:577-582.
7. Huang QR, Teusch SM, Buhler MM, Bennett BH, Heard RN, Manolios N, Stewart GJ: Evaluation of the Apo-1/Fas promoter MvaI polymorphism in multiple sclerosis. Mult Scler 2000;6:14-18.
8. Behrmann I, Walczak H, Krammer PH: Structure of the human APO-1 gene. Eur J Immunol 1994;24:3057-3062.
9. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235.
10. Olerup O, Aldener A, Fogdell A: HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-134.
11. Mullauer L, Gruber P, Sebinger D, et al: Mutations in apoptosis genes: A pathogenetic factor for human disease. Mutat Res 2001;488:211-231.
12. Watanabe-Fukunaga R: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
13. Ju ST, Panka DJ, Cui H, et al: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
14. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996;184:1513-1518.
15. Haynes JL, Ter-Minassian M, Bazyk A, et al: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996;13:469-471.
16. Ebers GC, Kukay K, Bulman DE, et al: A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476.
17. Niino M, Kikuchi S, Fukazawa T, Mitagishi R, Yabe I, Tashiro K: An examination of the Apo-I/Fas promoter MvaI polymorphism in Japanese patients with multiple sclerosis. BMC Neurol 2002;2:8.